Richard Steinhart
Directeur Financier/CFO chez BIOXCEL THERAPEUTICS, INC.
Fortune : 14 510 $ au 30/04/2024
Profil
Richard I.
Steinhart is an Independent Director at Atossa Therapeutics, Inc. since 2014, an Independent Director at Actinium Pharmaceuticals, Inc. since 2013, and the Chief Financial & Accounting Officer, Senior VP at BioXcel Therapeutics, Inc. since 2017.
He previously worked as an Independent Director at TG Therapeutics, Inc. from 2004 to 2012, a Managing Director at Forest Street Capital, LLC from 1992 to 2006, and a Managing Director at SAE Ventures.
He also served as the Chief Financial Officer & Vice President at Emisphere Technologies, Inc. from 1991 to 1992, the CFO, Secretary, Treasurer & Senior VP-Finance at STRATA Skin Sciences, Inc. from 2006 to 2013, and the Chief Financial Officer & General Partner at CW Group, Inc. from 1991 to 1992.
Additionally, he was the Chief Financial Officer & Vice President at Remedy Pharmaceuticals, Inc. from 2015 to 2017 and the Chief Financial Officer & SVP-Finance at MELA Sciences Inc. from 2012 to 2013.
Mr. Steinhart holds an undergraduate degree and an MBA from Pace University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/04/2024 | 4 765 ( 0,01% ) | 12 437 $ | 30/04/2024 | |
| 28/12/2023 | 316 ( 0,00% ) | 2 073 $ | 30/04/2024 | |
| 15/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Richard Steinhart
| Sociétés | Poste | Début |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/11/2013 |
| ATOSSA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/03/2014 |
| BIOXCEL THERAPEUTICS, INC. | Directeur Financier/CFO | 01/10/2017 |
Anciens postes connus de Richard Steinhart
| Sociétés | Poste | Fin |
|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Directeur Financier/CFO | 01/04/2017 |
| STRATA SKIN SCIENCES, INC. | Directeur Financier/CFO | 31/12/2013 |
| TG THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2012 |
| Forest Street Capital, LLC | Corporate Officer/Principal | 24/04/2006 |
| EMISPHERE TECHNOLOGIES, INC. | Directeur Financier/CFO | 01/05/1992 |
Formation de Richard Steinhart
| Pace University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| STRATA SKIN SCIENCES, INC. | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
| SAE Ventures | |
| MELA Sciences Inc. | |
| Forest Street Capital, LLC |
